BIOMAT Database Logo BIOMAT Database Logo

Bu-2313, a new antibiotic complex active against anaerobes. I. Production, isolation and properties of Bu-2313 A and B. 1980

H Tsukiura, and K Tomita, and M Hanada, and S Kobaru, and M Tsunakawa, and K Fujisawa, and H Kawaguchi

An unidentified oligosporic actinomycete strain, No. E864-61, produced two new antibiotics, Bu-2313 A (C27H35NO9) and Bu-2313 B (C26H33NO9). Bu-2313 A and B each exhibited a broad antibiotic spectrum against Gram-positive and Gram-negative anaerobic bacteria, and showed in vivo activity against experimental infections produced by B. fragilis and C. perfringens. Bu-2313 also inhibited some aerobic bacteria such as streptococci. Bu-2313 B was approximately two-fold more active than Bu-2313 A.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D000192 Actinomycetales An order of gram-positive, primarily aerobic BACTERIA that tend to form branching filaments. Corynebacteriaceae,Coryneform Group
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000693 Anaerobiosis The complete absence, or (loosely) the paucity, of gaseous or dissolved elemental oxygen in a given place or environment. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Anaerobic Metabolism,Anaerobic Metabolisms,Anaerobioses,Metabolism, Anaerobic,Metabolisms, Anaerobic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

H Tsukiura, and K Tomita, and M Hanada, and S Kobaru, and M Tsunakawa, and K Fujisawa, and H Kawaguchi
Bu-2313, a new antibiotic complex active against anaerobes. II. Structure determination of Bu-2313 A and B.
February 1980, The Journal of antibiotics,
H Tsukiura, and K Tomita, and M Hanada, and S Kobaru, and M Tsunakawa, and K Fujisawa, and H Kawaguchi
Bu-2313, a new antibiotic complex active against anaerobes. III. Semi-synthesis of Bu-2313 A and B, and their analogs.
February 1980, The Journal of antibiotics,
H Tsukiura, and K Tomita, and M Hanada, and S Kobaru, and M Tsunakawa, and K Fujisawa, and H Kawaguchi
Resistaphylin, a new antibiotic. I. Production, isolation and properties.
June 1971, The Journal of antibiotics,
H Tsukiura, and K Tomita, and M Hanada, and S Kobaru, and M Tsunakawa, and K Fujisawa, and H Kawaguchi
Capsimycin, a new antibiotic. I. Production, isolation and properties.
March 1979, The Journal of antibiotics,
H Tsukiura, and K Tomita, and M Hanada, and S Kobaru, and M Tsunakawa, and K Fujisawa, and H Kawaguchi
Sorbistin, a new aminoglycoside antibiotic complex of bacterial origin. I. Production, isolation and properties.
November 1976, The Journal of antibiotics,
H Tsukiura, and K Tomita, and M Hanada, and S Kobaru, and M Tsunakawa, and K Fujisawa, and H Kawaguchi
Verucopeptin, a new antitumor antibiotic active against B16 melanoma. I. Taxonomy, production, isolation, physico-chemical properties and biological activity.
June 1993, The Journal of antibiotics,
H Tsukiura, and K Tomita, and M Hanada, and S Kobaru, and M Tsunakawa, and K Fujisawa, and H Kawaguchi
Chicamycin, a new antitumor antibiotic. I. Production, isolation and properties.
March 1984, The Journal of antibiotics,
H Tsukiura, and K Tomita, and M Hanada, and S Kobaru, and M Tsunakawa, and K Fujisawa, and H Kawaguchi
Boholmycin, a new aminoglycoside antibiotic. I. Production, isolation and properties.
July 1988, The Journal of antibiotics,
H Tsukiura, and K Tomita, and M Hanada, and S Kobaru, and M Tsunakawa, and K Fujisawa, and H Kawaguchi
Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity.
January 1990, The Journal of antibiotics,
H Tsukiura, and K Tomita, and M Hanada, and S Kobaru, and M Tsunakawa, and K Fujisawa, and H Kawaguchi
Fredericamycin A, a new antitumor antibiotic. I. Production, isolation and physicochemical properties.
November 1981, The Journal of antibiotics,
Copied contents to your clipboard!